☆ 4.7 Article

CD5: from antiquated T cell marker to immunotherapy's new hope

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2023)

Related references

Note: Only part of the references are listed.

Article Multidisciplinary Sciences

CD5 expression by dendritic cells directs T cell immunity and sustains immunotherapy responses

Mingyu He et al.

Summary: The reduction of human CD1c+CD5+ dendritic cells (DCs) in melanoma-affected lymph nodes and the correlation between CD5 expression on DCs and patient survival have been observed. Activating CD5 on DCs enhances T cell priming and improves survival after immune checkpoint blockade (ICB) therapy. CD5+ DCs are essential for optimal ICB therapy.

SCIENCE (2023)

Add to Collection

Review Immunology

Suppressive mechanisms of regulatory B cells in mice and humans

Yutaka Matsumura et al.

Summary: B cells, including regulatory B cells (Bregs), regulate inflammation through an inhibitory mechanism mediated by interleukin 10 (IL-10). Bregs have been reported in various disease models and play a role in autoimmune diseases, infectious diseases, cancer, and organ-transplant rejection. In addition to IL-10, other cytokines and membrane-binding molecules are also involved in the suppressive functions of Bregs. The identification and classification of Breg fractions remains challenging due to the variations in their activity and differentiation stages in different disease models.

INTERNATIONAL IMMUNOLOGY (2023)

Add to Collection

Article Multidisciplinary Sciences

CD5 dynamically calibrates basal NF-xB signaling in T cells during thymic development and peripheral activation

Courtney A. Matson et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Add to Collection

Article Immunology

Human CD5 protects circulating tumor antigen-specific CTL from tumor-mediated activation-induced cell death

Grzegorz Friedlein et al.

JOURNAL OF IMMUNOLOGY (2007)

Add to Collection

Article Immunology

In situ sensory adaptation of tumor-infiltrating T lymphocytes to peptide-MHC levels elicits strong antitumor reactivity

G Dorothée et al.

JOURNAL OF IMMUNOLOGY (2005)

Add to Collection

CD5: from antiquated T cell marker to immunotherapy's new hope

Related references

CD5 expression by dendritic cells directs T cell immunity and sustains immunotherapy responses

Suppressive mechanisms of regulatory B cells in mice and humans

CD5 dynamically calibrates basal NF-xB signaling in T cells during thymic development and peripheral activation

Human CD5 protects circulating tumor antigen-specific CTL from tumor-mediated activation-induced cell death

In situ sensory adaptation of tumor-infiltrating T lymphocytes to peptide-MHC levels elicits strong antitumor reactivity

Export Citation

Share Paper